OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.18−0.18 (-12.96%)
Close on Nov 16, 2026Market cap $61.66MP/E –Yield –
OKYO Pharma cash
Cash and short-term investments held at the end of each period.
OKYO Pharma's cash was $14.59M at Mar 31, 2026. For fiscal 2026 it was $14.59M, up 835.0% from the year before. The highest annual figure on record is $14.59M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $14.59M | +835.0% |
| FY2025 | Mar 31, 2025 | $1.56M | +88.8% |
| FY2024 | Mar 31, 2024 | $826.85K | -79.6% |
| FY2023 | Mar 31, 2023 | $4.05M | +49.8% |
| FY2022 | Mar 31, 2022 | $2.70M | -60.8% |
| FY2021 | Mar 31, 2021 | $6.89M | +2825.6% |
| FY2020 | Mar 31, 2020 | $235.49K | -62.5% |
| FY2019 | Mar 31, 2019 | $627.62K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $14.59M | +440.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $1.56M | -77.3% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $826.85K | +251.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $4.05M | +544.6% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $2.70M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $6.89M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $235.49K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $627.62K | – |
See a number that looks wrong?